Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for iBio (IBIO) over the last 14 years, with Q4 2025 value amounting to $5000.0.

  • iBio's Amortizatization of Intangibles changed 0.0% to $5000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $194000.0, marking a year-over-year increase of 2356.69%. This contributed to the annual value of $351000.0 for FY2025, which is 934.58% up from last year.
  • Latest data reveals that iBio reported Amortizatization of Intangibles of $5000.0 as of Q4 2025, which was down 0.0% from $93000.0 recorded in Q3 2025.
  • iBio's Amortizatization of Intangibles' 5-year high stood at $416000.0 during Q3 2021, with a 5-year trough of $5000.0 in Q4 2023.
  • Over the past 5 years, iBio's median Amortizatization of Intangibles value was $77500.0 (recorded in 2022), while the average stood at $114100.0.
  • In the last 5 years, iBio's Amortizatization of Intangibles tumbled by 9710.84% in 2022 and then skyrocketed by 45000.0% in 2023.
  • Quarter analysis of 5 years shows iBio's Amortizatization of Intangibles stood at $123000.0 in 2021, then crashed by 39.02% to $75000.0 in 2022, then plummeted by 93.33% to $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Its Amortizatization of Intangibles was $5000.0 in Q4 2025, compared to $93000.0 in Q3 2025 and $91000.0 in Q2 2025.